Skip to content

Author

G. Rutigliano

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

852. Preclinical models of non dopaminergic antipsychotics

TAAR1 agonists provide a mechanistically distinct alternative to D2 antagonists, with potential advantages in tolerability and metabolic profile, and preclinical models support their relevance for symptom domains inadequately targeted by current therapies.

G. Rutigliano · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.